Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:05 pm
| PEG Ratio | 4.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
HLV Ltd operates in the Hotels, Resorts & Restaurants industry, with a current market capitalization of ₹541 Cr. The company’s share price stands at ₹8.25, reflecting a price-to-earnings (P/E) ratio of 52.9. Over the past few quarters, HLV Ltd has shown variability in its revenue performance. Sales reported for September 2022 were ₹35.42 Cr, which increased to ₹52.03 Cr by March 2023, indicating a robust recovery phase. However, sales fluctuated in subsequent quarters, with ₹41.37 Cr in September 2023 and a projected rise to ₹59.74 Cr by March 2024. This suggests a trend of growth despite seasonal impacts, as the company aims to stabilize its revenue streams. The trailing twelve months (TTM) sales stood at ₹194 Cr, reflecting a gradual recovery from prior lows, but still below historical highs, indicating potential growth opportunities.
Profitability and Efficiency Metrics
HLV Ltd’s profitability metrics reveal a challenging landscape, with an operating profit margin (OPM) of -17.33%. The company recorded a net profit of ₹8 Cr, with a return on equity (ROE) of 5.57% and a return on capital employed (ROCE) of 5.61%. These figures suggest that while the company is generating some profits, the margins remain under pressure, particularly with OPM showing significant volatility. The interest coverage ratio (ICR) reported at -33.49x further highlights the company’s struggle to meet interest obligations, raising concerns about financial sustainability. Additionally, the cash conversion cycle (CCC) of -2,102 days indicates inefficiencies in converting inventory and receivables into cash, which could impede liquidity. Overall, while HLV Ltd is on a recovery path, its profitability metrics suggest that significant operational improvements are necessary to enhance financial health.
Balance Sheet Strength and Financial Ratios
HLV Ltd’s balance sheet reflects a cautious financial posture, with total borrowings recorded at ₹38 Cr against reserves of ₹322 Cr. The price-to-book value (P/BV) ratio stands at 0.44x, indicating that the stock is trading at a discount relative to its book value, which may attract value-oriented investors. However, the company has faced challenges in terms of asset utilization, as evidenced by its ROCE of 5.61%, which is below the industry average. The high levels of debt relative to equity, illustrated by the long-term debt-to-equity ratio, suggest that HLV Ltd has been leveraging its balance sheet to fund operations. Total liabilities stood at ₹621 Cr, with fixed assets at ₹324 Cr, indicating a potential need for asset optimization. While the balance sheet shows some strength through retained earnings, the overall financial ratios signal a need for strategic management to bolster operational efficiency and profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of HLV Ltd indicates a diverse ownership structure, with promoters holding 39.07% of the shares, down from 49.57% in December 2022. Institutional investors have minimal representation, with foreign institutional investors (FIIs) at 0.09% and domestic institutional investors (DIIs) holding 1.56%. The public holds the majority stake at 59.27%, reflecting a growing retail investor base. The increase in the number of shareholders from 85,950 in December 2022 to 1,50,092 indicates rising investor interest, despite the recent decline in promoter holding. This shift may signal a broader market confidence in the company’s recovery trajectory. However, the low institutional participation could be a concern, as institutional investors often provide stability and credibility. Overall, while investor confidence appears to be improving, the reduced promoter stake might raise questions regarding long-term strategic direction.
Outlook, Risks, and Final Insight
HLV Ltd’s outlook hinges on its ability to stabilize revenue growth while improving operational efficiency. The company faces several risks, including high leverage indicated by a negative ICR, which could limit financial flexibility in adverse conditions. Additionally, the negative cash conversion cycle raises concerns about liquidity management, which could impact short-term operational capabilities. On the other hand, strengths include a significant reserve base that provides a buffer against short-term volatility and a low P/BV ratio that may attract value investors. The ongoing recovery in sales suggests potential for future growth, particularly if the company can enhance profitability metrics and operational efficiencies. As HLV Ltd navigates these challenges, its focus on improving cash flow management and operational performance will be crucial for sustaining investor confidence and achieving long-term objectives.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Howard Hotels Ltd | 20.1 Cr. | 22.0 | 33.9/18.0 | 27.5 | 11.2 | 0.00 % | 6.09 % | 3.55 % | 10.0 |
| HS India Ltd | 19.0 Cr. | 11.7 | 18.9/11.1 | 13.8 | 19.8 | 0.00 % | 7.04 % | 4.51 % | 10.0 |
| Gujarat Hotels Ltd | 81.7 Cr. | 216 | 355/196 | 14.2 | 132 | 1.39 % | 15.0 % | 11.4 % | 10.0 |
| Graviss Hospitality Ltd | 214 Cr. | 30.4 | 51.9/29.0 | 26.8 | 0.00 % | 1.18 % | 4.70 % | 2.00 | |
| Goel Food Products Ltd | 26.3 Cr. | 14.0 | 20.4/12.6 | 5.26 | 14.6 | 0.00 % | 17.5 % | 20.5 % | 10.0 |
| Industry Average | 8,162.76 Cr | 470.64 | 317.84 | 103.09 | 0.29% | 12.62% | 10.35% | 6.81 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35.42 | 45.49 | 52.03 | 42.62 | 41.37 | 55.37 | 59.74 | 42.95 | 43.37 | 57.73 | 59.26 | 40.74 | 35.83 |
| Expenses | 36.39 | 40.32 | 45.06 | 38.22 | 36.95 | 44.47 | 48.70 | 42.47 | 40.47 | 45.90 | 46.38 | 42.45 | 42.04 |
| Operating Profit | -0.97 | 5.17 | 6.97 | 4.40 | 4.42 | 10.90 | 11.04 | 0.48 | 2.90 | 11.83 | 12.88 | -1.71 | -6.21 |
| OPM % | -2.74% | 11.37% | 13.40% | 10.32% | 10.68% | 19.69% | 18.48% | 1.12% | 6.69% | 20.49% | 21.73% | -4.20% | -17.33% |
| Other Income | 1.34 | 2.88 | 8.18 | 1.59 | 1.78 | 2.88 | 3.55 | 5.18 | 4.95 | 3.08 | 2.69 | 3.23 | 1.97 |
| Interest | 1.20 | 1.17 | 1.45 | 0.63 | 0.61 | 0.60 | 0.56 | 0.54 | 0.52 | 0.59 | 0.58 | 0.61 | 0.83 |
| Depreciation | 2.74 | 2.80 | 2.95 | 3.46 | 3.57 | 3.65 | 3.68 | 3.50 | 3.84 | 4.05 | 4.25 | 4.38 | 4.85 |
| Profit before tax | -3.57 | 4.08 | 10.75 | 1.90 | 2.02 | 9.53 | 10.35 | 1.62 | 3.49 | 10.27 | 10.74 | -3.47 | -9.92 |
| Tax % | 0.00% | 24.51% | -0.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -3.57 | 3.08 | 10.79 | 1.90 | 2.02 | 9.53 | 10.35 | 1.62 | 3.49 | 10.27 | 10.74 | -3.47 | -9.92 |
| EPS in Rs | -0.05 | 0.05 | 0.16 | 0.03 | 0.03 | 0.14 | 0.16 | 0.02 | 0.05 | 0.16 | 0.16 | -0.05 | -0.15 |
Last Updated: January 1, 2026, 10:16 am
Below is a detailed analysis of the quarterly data for HLV Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 35.83 Cr.. The value appears to be declining and may need further review. It has decreased from 40.74 Cr. (Jun 2025) to 35.83 Cr., marking a decrease of 4.91 Cr..
- For Expenses, as of Sep 2025, the value is 42.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.45 Cr. (Jun 2025) to 42.04 Cr., marking a decrease of 0.41 Cr..
- For Operating Profit, as of Sep 2025, the value is -6.21 Cr.. The value appears to be declining and may need further review. It has decreased from -1.71 Cr. (Jun 2025) to -6.21 Cr., marking a decrease of 4.50 Cr..
- For OPM %, as of Sep 2025, the value is -17.33%. The value appears to be declining and may need further review. It has decreased from -4.20% (Jun 2025) to -17.33%, marking a decrease of 13.13%.
- For Other Income, as of Sep 2025, the value is 1.97 Cr.. The value appears to be declining and may need further review. It has decreased from 3.23 Cr. (Jun 2025) to 1.97 Cr., marking a decrease of 1.26 Cr..
- For Interest, as of Sep 2025, the value is 0.83 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.61 Cr. (Jun 2025) to 0.83 Cr., marking an increase of 0.22 Cr..
- For Depreciation, as of Sep 2025, the value is 4.85 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.38 Cr. (Jun 2025) to 4.85 Cr., marking an increase of 0.47 Cr..
- For Profit before tax, as of Sep 2025, the value is -9.92 Cr.. The value appears to be declining and may need further review. It has decreased from -3.47 Cr. (Jun 2025) to -9.92 Cr., marking a decrease of 6.45 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -9.92 Cr.. The value appears to be declining and may need further review. It has decreased from -3.47 Cr. (Jun 2025) to -9.92 Cr., marking a decrease of 6.45 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.15. The value appears to be declining and may need further review. It has decreased from -0.05 (Jun 2025) to -0.15, marking a decrease of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 718 | 636 | 661 | 698 | 138 | 154 | 146 | 19 | 73 | 173 | 199 | 203 | 194 |
| Expenses | 573 | 545 | 508 | 523 | 150 | 238 | 183 | 72 | 94 | 157 | 168 | 175 | 177 |
| Operating Profit | 145 | 92 | 153 | 175 | -12 | -83 | -37 | -53 | -21 | 16 | 31 | 28 | 17 |
| OPM % | 20% | 14% | 23% | 25% | -9% | -54% | -25% | -280% | -28% | 9% | 15% | 14% | 9% |
| Other Income | 50 | -138 | -13 | 41 | 2 | -25 | 243 | 33 | -7 | 9 | 10 | 16 | 11 |
| Interest | 502 | 198 | 88 | 90 | 0 | 0 | 1 | 2 | 2 | 5 | 2 | 2 | 3 |
| Depreciation | 181 | 227 | 240 | 141 | 13 | 10 | 12 | 14 | 13 | 11 | 14 | 16 | 18 |
| Profit before tax | -487 | -470 | -187 | -15 | -23 | -119 | 194 | -36 | -43 | 9 | 24 | 26 | 8 |
| Tax % | -9% | -12% | -4% | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 0% | 0% | |
| Net Profit | -441 | -416 | -180 | -15 | -23 | -119 | 194 | -36 | -43 | 8 | 24 | 26 | 8 |
| EPS in Rs | -9.78 | -8.91 | -3.86 | -0.33 | -0.37 | -1.89 | 3.07 | -0.57 | -0.64 | 0.12 | 0.36 | 0.40 | 0.12 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.67% | 56.73% | 91.67% | -53.33% | -417.39% | 263.03% | -118.56% | -19.44% | 118.60% | 200.00% | 8.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 51.06% | 34.94% | -145.00% | -364.06% | 680.42% | -381.58% | 99.11% | 138.05% | 81.40% | -191.67% |
HLV Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | 7% |
| 3 Years: | 41% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -32% |
| 3 Years: | 40% |
| TTM: | -14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 18% |
| 3 Years: | 5% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 4% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 6:25 am
Balance Sheet
Last Updated: December 10, 2025, 2:48 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 90 | 93 | 93 | 93 | 126 | 126 | 126 | 126 | 132 | 132 | 132 | 132 | 132 |
| Reserves | 780 | 325 | 145 | 38 | 258 | 140 | 331 | 296 | 280 | 287 | 312 | 336 | 322 |
| Borrowings | 4,905 | 5,034 | 4,329 | 4,182 | 3,781 | 3,610 | 33 | 56 | 48 | 33 | 33 | 41 | 38 |
| Other Liabilities | 510 | 376 | 396 | 421 | 396 | 313 | 169 | 119 | 100 | 114 | 104 | 123 | 130 |
| Total Liabilities | 6,285 | 5,828 | 4,963 | 4,734 | 4,562 | 4,189 | 660 | 596 | 560 | 566 | 580 | 632 | 621 |
| Fixed Assets | 5,533 | 5,291 | 4,391 | 3,983 | 3,822 | 344 | 329 | 316 | 298 | 312 | 309 | 318 | 324 |
| CWIP | 158 | 17 | 38 | 12 | 5 | 1 | 1 | 0 | 0 | 5 | 1 | 10 | 13 |
| Investments | 46 | 90 | 90 | 90 | 90 | 0 | 0 | 0 | 40 | 0 | 0 | 0 | 0 |
| Other Assets | 548 | 430 | 443 | 649 | 644 | 3,844 | 330 | 280 | 222 | 249 | 269 | 304 | 284 |
| Total Assets | 6,285 | 5,828 | 4,963 | 4,734 | 4,562 | 4,189 | 660 | 596 | 560 | 566 | 580 | 632 | 621 |
Below is a detailed analysis of the balance sheet data for HLV Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 132.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 132.00 Cr..
- For Reserves, as of Sep 2025, the value is 322.00 Cr.. The value appears to be declining and may need further review. It has decreased from 336.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 14.00 Cr..
- For Borrowings, as of Sep 2025, the value is 38.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 41.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 123.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 621.00 Cr.. The value appears to be improving (decreasing). It has decreased from 632.00 Cr. (Mar 2025) to 621.00 Cr., marking a decrease of 11.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 324.00 Cr.. The value appears strong and on an upward trend. It has increased from 318.00 Cr. (Mar 2025) to 324.00 Cr., marking an increase of 6.00 Cr..
- For CWIP, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 284.00 Cr.. The value appears to be declining and may need further review. It has decreased from 304.00 Cr. (Mar 2025) to 284.00 Cr., marking a decrease of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 621.00 Cr.. The value appears to be declining and may need further review. It has decreased from 632.00 Cr. (Mar 2025) to 621.00 Cr., marking a decrease of 11.00 Cr..
Notably, the Reserves (322.00 Cr.) exceed the Borrowings (38.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 141.00 | 87.00 | 149.00 | 171.00 | -15.00 | -86.00 | -70.00 | -109.00 | -69.00 | -17.00 | -2.00 | -13.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 29 | 35 | 37 | 219 | 155 | 19 | 55 | 24 | 28 | 27 | 22 |
| Inventory Days | 378 | 320 | 260 | 201 | 1,076 | 334 | 165 | 184 | 202 | |||
| Days Payable | 379 | 395 | 396 | 1,838 | 8,774 | 3,031 | 1,944 | 1,887 | 2,327 | |||
| Cash Conversion Cycle | 34 | -46 | -102 | 37 | 219 | 155 | -1,619 | -7,643 | -2,673 | -1,751 | -1,676 | -2,102 |
| Working Capital Days | -1,296 | -131 | -156 | -169 | -1,993 | -6,978 | -110 | -33 | -11 | -70 | -48 | -67 |
| ROCE % | -0% | -2% | 2% | 2% | 0% | -2% | 8% | -9% | -7% | 3% | 6% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 3.07 | -1.89 | -0.43 | -0.33 | -3.86 |
| Diluted EPS (Rs.) | 3.07 | -1.89 | -0.43 | -0.33 | -3.86 |
| Cash EPS (Rs.) | 3.26 | -0.44 | -0.61 | 2.69 | 1.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 7.25 | 4.21 | 6.09 | 2.81 | -3.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 7.25 | 4.21 | 6.09 | 2.81 | 5.09 |
| Revenue From Operations / Share (Rs.) | 2.31 | 2.45 | 2.19 | 14.96 | 14.16 |
| PBDIT / Share (Rs.) | -0.48 | 0.02 | -0.08 | 4.63 | 3.48 |
| PBIT / Share (Rs.) | -0.67 | -0.12 | -0.29 | 1.61 | -1.66 |
| PBT / Share (Rs.) | -0.32 | -0.59 | -0.82 | -0.33 | -8.11 |
| Net Profit / Share (Rs.) | 3.07 | -0.59 | -0.82 | -0.33 | -3.86 |
| NP After MI And SOA / Share (Rs.) | 3.07 | -1.89 | -0.36 | -0.33 | -3.86 |
| PBDIT Margin (%) | -20.90 | 1.18 | -4.00 | 30.96 | 24.59 |
| PBIT Margin (%) | -29.09 | -5.01 | -13.62 | 10.74 | -11.69 |
| PBT Margin (%) | -13.86 | -24.48 | -37.61 | -2.21 | -57.28 |
| Net Profit Margin (%) | 132.97 | -24.48 | -37.61 | -2.21 | -27.25 |
| NP After MI And SOA Margin (%) | 132.97 | -77.05 | -16.84 | -2.21 | -27.25 |
| Return on Networth / Equity (%) | 42.35 | -44.79 | -6.04 | -11.80 | 0.00 |
| Return on Capital Employeed (%) | -8.54 | -0.77 | -0.53 | 1.82 | -1.70 |
| Return On Assets (%) | 29.36 | -2.83 | -0.50 | -0.32 | -3.63 |
| Long Term Debt / Equity (X) | 0.01 | 2.68 | 8.00 | 30.05 | -24.31 |
| Total Debt / Equity (X) | 0.07 | 2.89 | 8.31 | 30.20 | -24.31 |
| Asset Turnover Ratio (%) | 0.06 | 0.03 | 0.02 | 0.14 | 0.12 |
| Current Ratio (X) | 1.58 | 1.18 | 0.45 | 0.79 | 0.44 |
| Quick Ratio (X) | 1.54 | 1.18 | 0.42 | 0.75 | 0.34 |
| Interest Coverage Ratio (X) | -33.49 | 4.63 | -43.50 | 2.39 | 1.85 |
| Interest Coverage Ratio (Post Tax) (X) | -46.61 | -19.51 | -147.91 | 0.82 | -0.80 |
| Enterprise Value (Cr.) | 215.95 | 1435.09 | 4251.79 | 4669.13 | 5054.72 |
| EV / Net Operating Revenue (X) | 1.48 | 9.30 | 30.85 | 6.69 | 7.65 |
| EV / EBITDA (X) | -7.09 | 781.38 | -769.67 | 21.60 | 31.09 |
| MarketCap / Net Operating Revenue (X) | 1.39 | 4.51 | 7.85 | 1.09 | 1.27 |
| Price / BV (X) | 0.44 | 2.62 | 2.81 | 5.81 | -4.81 |
| Price / Net Operating Revenue (X) | 1.39 | 4.51 | 7.85 | 1.09 | 1.27 |
| EarningsYield | 0.96 | -0.17 | -0.02 | -0.02 | -0.21 |
After reviewing the key financial ratios for HLV Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 3.07. This value is below the healthy minimum of 5. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
- For Diluted EPS (Rs.), as of Mar 20, the value is 3.07. This value is below the healthy minimum of 5. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
- For Cash EPS (Rs.), as of Mar 20, the value is 3.26. This value is within the healthy range. It has increased from -0.44 (Mar 19) to 3.26, marking an increase of 3.70.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 7.25. It has increased from 4.21 (Mar 19) to 7.25, marking an increase of 3.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 7.25. It has increased from 4.21 (Mar 19) to 7.25, marking an increase of 3.04.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 2.31. It has decreased from 2.45 (Mar 19) to 2.31, marking a decrease of 0.14.
- For PBDIT / Share (Rs.), as of Mar 20, the value is -0.48. This value is below the healthy minimum of 2. It has decreased from 0.02 (Mar 19) to -0.48, marking a decrease of 0.50.
- For PBIT / Share (Rs.), as of Mar 20, the value is -0.67. This value is below the healthy minimum of 0. It has decreased from -0.12 (Mar 19) to -0.67, marking a decrease of 0.55.
- For PBT / Share (Rs.), as of Mar 20, the value is -0.32. This value is below the healthy minimum of 0. It has increased from -0.59 (Mar 19) to -0.32, marking an increase of 0.27.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 3.07. This value is within the healthy range. It has increased from -0.59 (Mar 19) to 3.07, marking an increase of 3.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 3.07. This value is within the healthy range. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
- For PBDIT Margin (%), as of Mar 20, the value is -20.90. This value is below the healthy minimum of 10. It has decreased from 1.18 (Mar 19) to -20.90, marking a decrease of 22.08.
- For PBIT Margin (%), as of Mar 20, the value is -29.09. This value is below the healthy minimum of 10. It has decreased from -5.01 (Mar 19) to -29.09, marking a decrease of 24.08.
- For PBT Margin (%), as of Mar 20, the value is -13.86. This value is below the healthy minimum of 10. It has increased from -24.48 (Mar 19) to -13.86, marking an increase of 10.62.
- For Net Profit Margin (%), as of Mar 20, the value is 132.97. This value exceeds the healthy maximum of 10. It has increased from -24.48 (Mar 19) to 132.97, marking an increase of 157.45.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 132.97. This value exceeds the healthy maximum of 20. It has increased from -77.05 (Mar 19) to 132.97, marking an increase of 210.02.
- For Return on Networth / Equity (%), as of Mar 20, the value is 42.35. This value is within the healthy range. It has increased from -44.79 (Mar 19) to 42.35, marking an increase of 87.14.
- For Return on Capital Employeed (%), as of Mar 20, the value is -8.54. This value is below the healthy minimum of 10. It has decreased from -0.77 (Mar 19) to -8.54, marking a decrease of 7.77.
- For Return On Assets (%), as of Mar 20, the value is 29.36. This value is within the healthy range. It has increased from -2.83 (Mar 19) to 29.36, marking an increase of 32.19.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 2.68 (Mar 19) to 0.01, marking a decrease of 2.67.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.07. This value is within the healthy range. It has decreased from 2.89 (Mar 19) to 0.07, marking a decrease of 2.82.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 0.06. It has increased from 0.03 (Mar 19) to 0.06, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 20, the value is 1.58. This value is within the healthy range. It has increased from 1.18 (Mar 19) to 1.58, marking an increase of 0.40.
- For Quick Ratio (X), as of Mar 20, the value is 1.54. This value is within the healthy range. It has increased from 1.18 (Mar 19) to 1.54, marking an increase of 0.36.
- For Interest Coverage Ratio (X), as of Mar 20, the value is -33.49. This value is below the healthy minimum of 3. It has decreased from 4.63 (Mar 19) to -33.49, marking a decrease of 38.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -46.61. This value is below the healthy minimum of 3. It has decreased from -19.51 (Mar 19) to -46.61, marking a decrease of 27.10.
- For Enterprise Value (Cr.), as of Mar 20, the value is 215.95. It has decreased from 1,435.09 (Mar 19) to 215.95, marking a decrease of 1,219.14.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 1.48. This value is within the healthy range. It has decreased from 9.30 (Mar 19) to 1.48, marking a decrease of 7.82.
- For EV / EBITDA (X), as of Mar 20, the value is -7.09. This value is below the healthy minimum of 5. It has decreased from 781.38 (Mar 19) to -7.09, marking a decrease of 788.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 1.39. This value is within the healthy range. It has decreased from 4.51 (Mar 19) to 1.39, marking a decrease of 3.12.
- For Price / BV (X), as of Mar 20, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 2.62 (Mar 19) to 0.44, marking a decrease of 2.18.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 1.39. This value is within the healthy range. It has decreased from 4.51 (Mar 19) to 1.39, marking a decrease of 3.12.
- For EarningsYield, as of Mar 20, the value is 0.96. This value is below the healthy minimum of 5. It has increased from -0.17 (Mar 19) to 0.96, marking an increase of 1.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in HLV Ltd:
- Net Profit Margin: 132.97%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -8.54% (Industry Average ROCE: 12.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 42.35% (Industry Average ROE: 10.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -46.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.54
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 54.1 (Industry average Stock P/E: 317.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 132.97%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hotels, Resorts & Restaurants | The Leela, Sahar, Mumbai Maharashtra 400059 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vivek Nair | Chairman & Managing Director |
| Mr. Dinesh Nair | Co-Chairman & Manag. Director |
| Ms. Amruda Nair | Director |
| Mr. Ashok Rajani | Director |
| Ms. Niranjana Unnikrishnan | Director |
| Mr. Shereveer Vakil | Director |
| Mrs. Salini Madhu Nair | Director |
| Ms. Saija Nair | Director |
| Mr. Vinay Kapadia | Director |
FAQ
What is the intrinsic value of HLV Ltd?
HLV Ltd's intrinsic value (as of 25 January 2026) is ₹18.95 which is 125.33% higher the current market price of ₹8.41, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹554 Cr. market cap, FY2025-2026 high/low of ₹16.9/8.05, reserves of ₹322 Cr, and liabilities of ₹621 Cr.
What is the Market Cap of HLV Ltd?
The Market Cap of HLV Ltd is 554 Cr..
What is the current Stock Price of HLV Ltd as on 25 January 2026?
The current stock price of HLV Ltd as on 25 January 2026 is ₹8.41.
What is the High / Low of HLV Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of HLV Ltd stocks is ₹16.9/8.05.
What is the Stock P/E of HLV Ltd?
The Stock P/E of HLV Ltd is 54.1.
What is the Book Value of HLV Ltd?
The Book Value of HLV Ltd is 6.88.
What is the Dividend Yield of HLV Ltd?
The Dividend Yield of HLV Ltd is 0.00 %.
What is the ROCE of HLV Ltd?
The ROCE of HLV Ltd is 5.61 %.
What is the ROE of HLV Ltd?
The ROE of HLV Ltd is 5.57 %.
What is the Face Value of HLV Ltd?
The Face Value of HLV Ltd is 2.00.